Spark Therapeutics is working on an experimental gene therapy for an inherited eye disorder, and it has the potential to be the first gene therapy on the market in the U.S.» Read More
Democratic presidential candidate Hillary Clinton unveils her plan to lower prescription drug costs.
Democratic presidential candidate Hillary Clinton addresses innovation in the pharmaceutical and biotech industries, and unveils her plan to lower prescription drug costs.
Dr. Peter Bach, MD of Memorial Sloan Kettering Cancer Center, weighs in on Turing Pharmaceuticals' decision to increase a single dose of Daraprim from $13.50 to $750.
CNBC's Meg Tirrell reports on Hillary Clinton's drug plan, one day after she criticized drug price gouging.
Hillary Clinton is criticizing drug price gouging. Steve Case, Revolution Chairman and CEO, shares his take.
Hillary Clinton is criticizing drug price gouging, after news a drug company hiked the price of one of its drugs by 5,000 percent overnight, with CNBC's Meg Tirrell.
*Forecasts profit of $0.12- $0.19/ shr. Sept 17- Drugstore chain operator Rite Aid Corp cut its full-year forecasts for total earnings and drugstore sales, citing lower pharmacy reimbursements and expenses related to its $2 billion acquisition of pharmacy benefit manager EnvisionRx. Rite Aid shares fell nearly 9 percent in morning trading on Thursday.
Sept 17- Drugstore chain operator Rite Aid Corp cut its full-year forecast for drugstore sales and total earnings, citing "recent sales trends" and expenses related to its $2 billion acquisition of pharmacy benefit manager EnvisionRx. Rite Aid cut its drugstore sales forecast for the year ending February to $26.7 billion- $27.0 billion from $26.9 billion-...
Sept 17- Drugstore chain operator Rite Aid Corp reported a 17.5 percent rise in quarterly revenue, helped by its $2 billion acquisition of pharmacy benefit manager EnvisionRx. Net income fell to $21.5 million, or 2 cents per share, in the second quarter ended Aug. 29, from $127.8 million, or 13 cents per share, a year earlier. Revenue rose to $7.66 billion from $6.52...
CNBC's Jane Wells reports from Arcata, California, where the city council wants to build the country's first marijuana innovation zone.
A new government study on blood pressure found potentially lifesaving results, reports CNBC's Meg Tirrell.
Disappointing clinical results for GSK-Theravance respiratory treatment.
CHICAGO, Sept 3- CVS Health Corp said on Thursday its decision to stop selling tobacco products last year led to a 1 percent decrease in cigarette sales in some states where the drugstore chain has a sizeable presence. The September 2014 decision hurt sales, with general merchandise revenue at CVS pharmacies open at least a year falling 7.8 percent in the second...
Amgen wins FDA approval for cholesterol-lowering drug Repatha.
Abbott denies FT speculation about a St. Jude's acquisition.
Shares of Valeant are down 6 percent after buying Sprout Pharmaceuticals, the maker of the "female Viagra" drug. CNBC's Meg Tirrell discusses drug deals.
Valeant to purchase flibanserin-maker Sprout for $1 billion.
The FDA approved the first prescription drug for enhancing female libido.
Wal-Mart Stores Inc said on Tuesday that lower margins in its pharmacy business had emerged as a drag on profits, as it gets paid less by drug plan managers and as fewer customers pay in cash, since Obamacare has increased the ranks of insured Americans. The company warned that the margin squeeze would continue for at least the remainder of the year, although a...
Aug 18- Wal-Mart Stores Inc reported weaker quarterly earnings and lowered its annual forecast on Tuesday, as it copes with higher labor costs, a squeeze on pharmacy margins and sliding sales at its British supermarket chain. Net profit attributable to Wal-Mart fell to $3.48 billion, or $1.08 per share, in the second quarter ended July 31, from $3.92 billion, or...